The most recent trading session ended with Vertex Pharmaceuticals (VRTX) standing at $416.96, reflecting a -1.72% shift from the previouse trading day's closing. The stock's performance was behind the ...

The biotechnology market experiences significant growth, fueled by advancements in genetic therapies and supportive global ...

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Incyte (INCY) and Vertex Pharmaceuticals (VRTX ... of our Style Scores system. The proven Zacks Rank ...

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published ...

Jefferies analyst Michael Yee has maintained their bullish stance on VRTX stock, giving a Buy rating today. Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter ...

Avi Kapoor Vertex Grapples With Bearish Chart As Death Cross Emerges Vertex Pharmaceuticals (VRTX) is facing technical challenges, with its stock forming a Death Cross and down 15% in 6 months.

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Bristol Myers Squibb (BMY) or Vertex Pharmaceuticals (VRTX). But which of these two ...